Striving Towards EmPowerment and Medication Adherence R01
This is a study for Black women living with HIV to test a counseling program for Black women living with HIV. This participant may be a good fit if the participant is a Black woman, living with HIV, has a history of trauma, and is currently taking Antiretroviral Therapy (ART) medicines
Conditions:
🦠 Hiv 🦠 Mental Health Issue
🗓️ Study Start (Actual) July 2024
🗓️ Primary Completion (Estimated) 1 June 2029
✅ Study Completion (Estimated) 1 June 2029
👥 Enrollment (Estimated) 250
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Miami, Florida, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • 1. Black
    • 2. Living with HIV
    • 3. Cis-gender female
    • 4. Age 18 or older
    • 5. English speaking
    • 6. Viral load non-suppression (\>200 ml) within the past year
    • 7. History of trauma/abuse
    • 8. Capable of completing and fully understanding the informed consent process and study procedures

    Exclusion Criteria:

    • 1. Unable to completely and fully understand the informed consent process and the study procedures
    • 2. Significantly interfering mental health symptoms (e.g., active psychosis that is untreated)
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 10 June 2024
  • First Submitted that Met QC Criteria 10 June 2024
  • First Posted 18 June 2024

Study Record Updates

  • Last Update Submitted that Met QC Criteria 16 July 2024
  • Last Update Posted 18 July 2024
  • Last Verified July 2024